financetom
Business
financetom
/
Business
/
EU approves Omnicom's acquisition of IPG without conditions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU approves Omnicom's acquisition of IPG without conditions
Nov 24, 2025 3:15 AM

BRUSSELS (Reuters) -The EU Commission on Monday said it had unconditionally approved Omnicom Group's ( OMC ) $13.25 billion all-stock deal to buy rival Interpublic Group.

The deal, announced last December, merges the world's third-largest ad buyer, Omnicom ( OMC ), with the fourth-largest which is Interpublic.

It would create the world's largest advertising agency as traditional players look to better compete with Big Tech firms amid the accelerating use of AI.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biotech firm PepGen's Q3 net loss narrows to $18 mln
Biotech firm PepGen's Q3 net loss narrows to $18 mln
Nov 12, 2025
Overview * PepGen ( PEPG ) Q3 net loss narrows to $18 mln from $21.4 mln in 2024 * Company raised $115 mln, extending cash runway into 2H 2027 * FREEDOM-DM1 study shows highest mean splicing correction in DM1 patients Outlook * PepGen expects FREEDOM2 5 mg/kg cohort results in Q1 2026 * Company plans to initiate 10 mg/kg dosing...
EU looks to Big Tech, influencers to fight hybrid threats, fake news
EU looks to Big Tech, influencers to fight hybrid threats, fake news
Nov 12, 2025
BRUSSELS, Nov 12 (Reuters) - Europe is looking to online platforms and influencers to help fight disinformation and promote democracy according to a European Commission strategy presented on Wednesday amid concerns over interference by foreign governments in national elections. Alphabet's Google, Microsoft ( MSFT ), Meta Platforms ( META ), Elon Musk's X, TikTok and other online platforms already have...
Legend Biotech Q3 revenue slightly misses estimates
Legend Biotech Q3 revenue slightly misses estimates
Nov 12, 2025
Overview * Legend Biotech ( LEGN ) Q3 revenue slightly misses analyst expectations * Collaboration revenue rises due to CARVYKTI sales under Janssen Agreement * Company maintains $1.0 bln cash position, supporting operations beyond 2026 Outlook * Legend Biotech ( LEGN ) expects CARVYKTI profitability by year-end 2025 * Company anticipates company-wide profitability in 2026 * Commercial production in Belgium...
Medical tech firm Sanara's Q3 revenue misses estimates after Tissue Health Plus unit closure
Medical tech firm Sanara's Q3 revenue misses estimates after Tissue Health Plus unit closure
Nov 12, 2025
Overview * Sanara Q3 revenue grows 22% yr/yr to $26.3 mln, missing analyst expectations * Net income from continuing operations improved to $0.8 mln from a loss last year * Company ceases Tissue Health Plus operations for strategic realignment Outlook * Company expects strong, sustainable revenue growth for remainder of 2025 Result Drivers * SOFT TISSUE SALES - Revenue growth...
Copyright 2023-2026 - www.financetom.com All Rights Reserved